COMP <GO>
FENC vs AUTL // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Fennec Pharmaceuticals Inc. (NASDAQ) VS. Autolus Therapeutics plc (NASDAQ) • 15-METRIC TALLY: FENC 4
— AUTL 3
■ METRIC PARITY
LAST: $10.54 (+2.93%) • MKT CAP: $358.7M
options-implied-move
—
LAST: $1.42 (-6.58%) • MKT CAP: $404.6M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FENC VS. AUTL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FENC | AUTL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | -27.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -25.90% | -35.00% | +9.10 | FENC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.25% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -14.10% | -60.00% | +45.90 | FENC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -6.10% | 180.00% | -186.10 | AUTL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.31 | 0.20 | +3.11 | FENC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | AUTL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.3 | 38.4 | +7.90 | FENC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $358.7M | $404.6M | -$45.8M | AUTL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FENC REV | AUTL REV | FENC GROSS % | AUTL GROSS % | FENC FCF | AUTL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.6M | $75.4M | — | -27.8% | -$12.5M | -$302.6M |
| FY 2024 | $47.5M | $10.1M | — | -12.5% | $27.0M | -$228.3M |
| FY 2023 | $21.3M | $1.7M | — | — | -$17.1M | -$145.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FENC // BETA —
AUTL // BETA —